Search

everythinglearnresearchcommunity

for

Search:↓

The woman had a rare adrenal tumor removed, and she recovered well with no signs of the tumor returning.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Dutasteride is approved to help manage prostate enlargement.

Finasteride reduces prostate size, improves urination, and slows prostate cancer progression.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

PRP treatment may help improve hair density and thickness in breast cancer patients with therapy-induced hair loss.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

Combination therapies are more effective for treating androgenetic alopecia than single treatments.

AR-27 E-Chol siRNA can effectively promote hair regrowth for androgenetic alopecia.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

The document concludes that the risk of sexual side effects from 5-alpha-reductase inhibitors is low and often temporary, but more research is needed on potential permanent effects.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Oral and topical 5-alpha reductase inhibitors affect DHT levels and hair density differently in treating hair loss.

Surgery resolved hormone imbalance and symptoms in a rare ovarian tumor case in an elderly woman.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Ovulation inhibitors effectively treat menstrual issues and improve fertility but can have side effects.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Androgens and DHEA can help prevent breast cancer and improve health in women.

Combination therapies for androgenetic alopecia are more effective, but more research is needed for safe, standardized treatments.

Dutasteride helps hair growth in those unresponsive to finasteride, but may cause more sexual dysfunction.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

Masculinizing hormone therapy increases the risk of hair loss in transgender and gender-diverse patients.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.